Clinical Utility of Fedratinib in Myelofibrosis

Waksal, JA; Tremblay, D; Mascarenhas, J

Mascarenhas, J (corresponding author), Icahn Sch Med Mt Sinai, Tisch Canc Inst, Dept Hematol & Oncol, New York, NY 10029 USA.

ONCOTARGETS AND THERAPY, 2021; 14 (): 4509

Abstract

Myelofibrosis (MF) is a clonal hematologic malignancy characterized by bone marrow fibrosis, extramedullary hematopoiesis, splenomegaly, and constitut......

Full Text Link